Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)
China Parade a Welcome Distraction from Market Turmoil
42:52 - A holiday in China gave investors respite from the market that’s been at the center of recent global volatility. As fighter jets streaked through the skies of Beijing and tanks rolled through Tiananmen Square to commemorate the end of World War II, Chinese President Xi Jinping told the world that the nation was committed to peace and announced the biggest cuts to the army in almost two decades.
  • China Celebrates WWII Victory Amid Economic Slowdown
  • ECB on Inflation: What Can You Expect?
  • Budapest Trains Suspended as Refugees Flood Station